Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Takaji Wakita, Ann E. Sluder et al.|Journal of Hepatology|2016Cited by 126
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting PolypeptideManabu Kaneko, Takaji Wakita, Koichi Watashi et al.|Journal of Virology|2015Cited by 97